Suppr超能文献

Leber遗传性视神经病变(LHON)患者的临床概况:一项对北印度队列的双向性研究

Clinical Profile of Patients with Leber Hereditary Optic Neuropathy (LHON): An Ambispective Study of North Indian Cohorts.

作者信息

Wilson Vinny, Kaur Prabhjit, Singh Sofia, Ramachandran Radhika P, Jyothi Vislavath, Mahesh Karthik V, Takkar Aastha, Chandak Giriraj, Singh Ramandeep

机构信息

Department of Neurology, Armed Forces Medical College, Pune, Maharashtra, India.

Department of Neurology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

出版信息

Ann Indian Acad Neurol. 2022 Oct;25(Suppl 2):S65-S69. doi: 10.4103/aian.aian_532_22. Epub 2022 Oct 19.

Abstract

BACKGROUND

Leber hereditary optic neuropathy (LHON) is a maternally inherited disease resulting in irreversible visual loss usually in patients belonging to the age group of 15-35 years. Clinically, the patients present with sequential or bilateral, painless, progressive visual loss with central (or ceco-central) scotomas. Although the three mutations, namely, G11778A, T14484C, and G3460A contribute to >95% of LHON cases globally, the relative frequency of each mutation varies.

AIMS AND OBJECTIVES

We aimed to assess the clinical and genetic profile of patients with mutation-positive LHON at a north Indian tertiary care center.

MATERIALS AND METHODOLOGY

One hundred sixty-one patients (61 prospective and 100 retrospective) presenting with the clinical diagnosis of LHON were screened for the three known mitochondrial mutations (G1178A, G3460A, T14448C). Patients were assessed for detailed clinical, ophthalmological, and neurological examinations. Five milliliter of blood sample was taken to assess the three known mutations using DNA isolation and Sanger sequencing.

RESULTS AND DISCUSSION

Clinical profile of 83 patients with both positive and negative mutations was analyzed. Twenty-three out of 161 patients (14.3%) tested positive for either of the three mutations. The majority of the patients harbored G11778A mutation (56.52%) followed by T14484C (34.78%) and G3460A (8.69%). No statistical difference could be noted between the clinical profiles of mutation-negative and -positive patients.

摘要

背景

Leber遗传性视神经病变(LHON)是一种母系遗传疾病,通常导致15至35岁年龄组患者出现不可逆的视力丧失。临床上,患者表现为相继或双侧无痛性进行性视力丧失,并伴有中心(或旁中心)暗点。尽管三种突变,即G11778A、T14484C和G3460A在全球LHON病例中占比超过95%,但每种突变的相对频率有所不同。

目的

我们旨在评估印度北部一家三级医疗中心突变阳性LHON患者的临床和基因特征。

材料与方法

对161例临床诊断为LHON的患者(61例前瞻性和100例回顾性)进行三种已知线粒体突变(G1178A、G3460A、T14448C)的筛查。对患者进行详细的临床、眼科和神经学检查。采集5毫升血液样本,通过DNA分离和桑格测序评估三种已知突变。

结果与讨论

分析了83例突变阳性和阴性患者的临床特征。161例患者中有23例(14.3%)三种突变中的任何一种检测呈阳性。大多数患者携带G11778A突变(56.52%),其次是T14484C(34.78%)和G3460A(8.69%)。突变阴性和阳性患者的临床特征之间未观察到统计学差异。

相似文献

1
Clinical Profile of Patients with Leber Hereditary Optic Neuropathy (LHON): An Ambispective Study of North Indian Cohorts.
Ann Indian Acad Neurol. 2022 Oct;25(Suppl 2):S65-S69. doi: 10.4103/aian.aian_532_22. Epub 2022 Oct 19.
2
The epidemiology and mutation types of Leber's hereditary optic neuropathy in Thailand.
Ann Med. 2022 Dec;54(1):1601-1607. doi: 10.1080/07853890.2022.2082517.
3
A Meta-analysis of the association between different genotypes (, and ) of Leber hereditary optic neuropathy and visual prognosis.
Int J Ophthalmol. 2016 Oct 18;9(10):1493-1498. doi: 10.18240/ijo.2016.10.21. eCollection 2016.
5
Frequency of primary mutations of Leber's hereditary optic neuropathy patients in North Indian population.
Indian J Ophthalmol. 2017 Nov;65(11):1156-1160. doi: 10.4103/ijo.IJO_380_17.

引用本文的文献

2
Clinical Profile of Patients with Leber Hereditary Optic Neuropathy-An Ambispective Study in Cohort from Northern Part of India.
Ann Indian Acad Neurol. 2023 May-Jun;26(3):285-286. doi: 10.4103/aian.aian_973_22. Epub 2023 Jun 15.
3
Diagnosing Leber's Hereditary Optic Neuropathy Requires Documentation of a Causative mtDNA Variant.
Ann Indian Acad Neurol. 2023 Jan-Feb;26(1):80-81. doi: 10.4103/aian.aian_863_22. Epub 2023 Jan 17.

本文引用的文献

1
Establishing risk of vision loss in Leber hereditary optic neuropathy.
Am J Hum Genet. 2021 Nov 4;108(11):2159-2170. doi: 10.1016/j.ajhg.2021.09.015. Epub 2021 Oct 19.
2
Leber's hereditary optic neuropathy: Current approaches and future perspectives on Mesenchymal stem cell-mediated rescue.
Mitochondrion. 2021 Sep;60:201-218. doi: 10.1016/j.mito.2021.08.013. Epub 2021 Aug 26.
4
Treatment of Leber's hereditary optic neuropathy: An overview of recent developments.
Eur J Ophthalmol. 2020 Nov;30(6):1220-1227. doi: 10.1177/1120672120936592. Epub 2020 Jun 19.
5
Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy.
Ophthalmology. 2020 May;127(5):679-688. doi: 10.1016/j.ophtha.2019.11.014. Epub 2019 Nov 25.
6
Mutation analysis of Leber's hereditary optic neuropathy using a multi-gene panel.
Biomed Rep. 2018 Jan;8(1):51-58. doi: 10.3892/br.2017.1014. Epub 2017 Nov 8.
7
Frequency of primary mutations of Leber's hereditary optic neuropathy patients in North Indian population.
Indian J Ophthalmol. 2017 Nov;65(11):1156-1160. doi: 10.4103/ijo.IJO_380_17.
8
Mitochondrial genetics and therapeutic overview of Leber's hereditary optic neuropathy.
Indian J Ophthalmol. 2017 Nov;65(11):1087-1092. doi: 10.4103/ijo.IJO_358_17.
9
Identification of an ND4 Mutation in Leber Hereditary Optic Neuropathy.
Optom Vis Sci. 2017 Dec;94(12):1090-1094. doi: 10.1097/OPX.0000000000001147.
10
Prevalence and Genetics of Leber Hereditary Optic Neuropathy in the Danish Population.
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1370-5. doi: 10.1167/iovs.15-18306.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验